Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Qu Biologics completes venture financing

    Qu Biologics Inc., Vancouver, B.C. Business: Autoimmune, Cancer Date completed: 2016-04-12 Type: Venture financing Raised: C$4 million ($3.1 million)

    Published on 4/18/2016
  • RefleXion Medical completes venture financing

    RefleXion Medical Inc., Hayward, Calif. Business: Diagnostic Date completed: 2016-04-14 Type: Venture financing Raised: $46 million Investors: KCK Group; Pfizer Venture Investments; Venrock; Sofinnova Partners

    Published on 4/18/2016
  • Stat-Diagnostica and Innovation completes venture financing

    Stat-Diagnostica and Innovation, Barcelona, Spain Business: Diagnostic Date completed: 2016-04-11 Type: Venture financing Raised: EUR25 million ($28.4 million) Investors: Gilde Healthcare Partners; Kurma Partners; Ysios…

    Published on 4/18/2016
  • TargEDys completes venture financing

    TargEDys, Rouen, France Business: Endocrine/Metabolic, Neurology Date completed: 2016-04-14 Type: Venture financing Raised: EUR5.8 million ($6.6 million) Investors: Seventure Partners; NCI Gestion; Pontifax

    Published on 4/18/2016
  • Aeglea financial update

    Aeglea BioTherapeutics Inc. (NASDAQ:AGLE), Austin, Texas Business: Cancer, Endocrine/Metabolic Date announced: 2016-04-12 Note: Aeglea raised $4.8 million through the sale of 481,940 shares at $10 to cover the …

    Published on 4/18/2016
  • Amyris financial update

    Amyris Inc. (NASDAQ:AMRS), Emeryville, Calif. Business: Biomanufacturing, Supply/Service Date announced: 2016-03-08 Note: Amyris established an at-the-market program to sell up to $50 million of its shares. FBR Capital …

    Published on 4/18/2016
  • Flatiron Health financial update

    Flatiron Health Inc., New York, N.Y. Business: Bioinformatics Date announced: 2016-04-08 Note: Flatiron raised an undisclosed amount in a second tranche of a series C round, bringing the total raised in the round to $…

    Published on 4/18/2016
  • Forbion Capital Partners financial update

    Forbion Capital Partners, Naarden, the Netherlands Business: Finance Date announced: 2016-04-12 Note: Forbion Capital Partners closed its third life sciences fund, Forbion Capital Fund III, at EUR183 million ($208.2 …

    Published on 4/18/2016
  • Illumina Ventures financial update

    Illumina Ventures, San Diego, Calif. Business: Finance Date announced: 2016-04-14 Note: Illumina Inc. (NASDAQ:ILMN, San Diego, Calif.) has committed to invest $100 million over 10 years in new VC firm Illumina Ventures.…

    Published on 4/18/2016
  • InspireMD proposes private placement of convertible preferred stock and warrants

    InspireMD Inc. (NYSE-M:NSPR), Tel Aviv, Israel Business: Cardiovascular Date announced: 2016-04-14 Type: Private placement of convertible preferred stock and warrants To be raised: TBD Shares: TBD Price prior: $0.57 …

    Published on 4/18/2016
  • Intellia Therapeutics proposes IPO

    Intellia Therapeutics Inc., Cambridge, Mass. Business: Gene/Cell therapy, Genomics, Cancer Date announced: 2016-04-11 Type: IPO To be raised: Up to $120 million Shares: TBD Price: TBD Underwriters: Credit Suisse; …

    Published on 4/18/2016
  • Bavarian Nordic withdraws follow-on

    Bavarian Nordic A/S (CSE:BAVA), Kvistgaard, Denmark Business: Infectious, Cancer Date announced: 2016-04-13 Type: Follow-on Underwriters: Cowen; Piper Jaffray; Nomura; BTIG Note: Bavarian Nordic withdrew its offering to…

    Published on 4/18/2016
  • GenSight Biologics withdraws IPO

    GenSight Biologics S.A., Paris, France Business: Ophthalmic Date announced: 2016-04-14 Type: IPO Underwriters: Leerink Partners; Evercore; Canaccord Note: GenSight withdrew its IPO on NASDAQ, citing market conditions.

    Published on 4/18/2016
  • Aeglea completes IPO

    Aeglea BioTherapeutics Inc. (NASDAQ:AGLE), Austin, Texas Business: Cancer, Endocrine/Metabolic Date completed: 2016-04-07 Type: IPO Raised: $50 million Shares: 5 million Price: $10 Shares after offering: 12.9 million …

    Published on 4/11/2016
  • Alder completes follow-on

    Alder Biopharmaceuticals Inc. (NASDAQ:ALDR), Bothell, Wash. Business: Antibodies, Autoimmune, Cancer Date completed: 2016-04-07 Type: Follow-on Raised: $125 million Shares: 5.4 million Price: $23.25 Shares after …

    Published on 4/11/2016
  • Entasis Therapeutics completes venture financing

    Entasis Therapeutics Inc., Waltham, Mass. Business: Infectious Date completed: 2016-04-04 Type: Venture financing Raised: $50 million Investors: Clarus Securities Inc.; Frazier Healthcare; Novo A/S; Eventide Asset …

    Published on 4/11/2016
  • Galapagos completes warrant exercise

    Galapagos N.V. (Euronext:GLPG; NASDAQ:GLPG), Mechelen, Belgium Business: Autoimmune, Musculoskeletal, Functional genomics Date completed: 2016-04-03 Type: Warrant exercise Raised: EUR1.4 million ($1.6 million) Shares: …

    Published on 4/11/2016
  • GeneNews completes private placement

    GeneNews Ltd. (TSX:GEN), Markham, Ontario Business: Diagnostic Date completed: 2016-04-07 Type: Private placement Raised: C$560,000 ($428,232) Shares: 5.6 million Price: C$0.10 Shares after offering: 61.6 million …

    Published on 4/11/2016
  • Human Longevity completes venture financing

    Human Longevity Inc., San Diego, Calif. Business: Genomics, Cancer, Endocrine/Metabolic Date completed: 2016-04-04 Type: Venture financing Raised: $220 million Investors: Illumina Inc.; Celgene Corp.; GE Ventures; …

    Published on 4/11/2016
  • Lumos completes venture financing

    Lumos Pharma Inc., Austin, Texas Business: Endocrine/Metabolic Date completed: 2016-04-06 Type: Venture financing Raised: $34 million Investors: Deerfield Management; Clarus Ventures; Roche Venture Fund; New Enterprise …

    Published on 4/11/2016
  • MedDay completes venture financing

    MedDay S.A., Paris, France Business: Neurology Date completed: 2016-04-08 Type: Venture financing Raised: EUR34 million ($38.7 million) Investors: Edmond de Rothschild Investment Partners; Sofinnova Partners; InnoBio …

    Published on 4/11/2016
  • Novacyt completes private placement

    Novacyt S.A. (Euronext:ALNOV), Velizy-Villacoublay, France Business: Supply/Service Date completed: 2016-04-01 Type: Private placement Raised: EUR2 million ($2.3 million) Shares: 1.4 million Shares after offering: 8.6 …

    Published on 4/11/2016
  • Sunesis completes debt financing

    Sunesis Pharmaceuticals Inc. (NASDAQ:SNSS), South San Francisco, Calif. Business: Cancer Date completed: 2016-04-01 Type: Debt financing Raised: $15 million Shares outstanding prior: 86.5 million Investors: Bridge Bank;…

    Published on 4/11/2016
  • Thermo Fisher completes private placement of senior notes

    Thermo Fisher Scientific Inc. (NYSE:TMO), Waltham, Mass. Business: Supply/Service Date completed: 2016-04-04 Type: Private placement of senior notes Raised: $1 billion Underwriters: BofA Merrill Lynch; Goldman Sachs; …

    Published on 4/11/2016
  • ValiRx completes private placement of convertible notes

    ValiRx plc (LSE:VAL), London, U.K. Business: Cancer, Diagnostic Date completed: 2016-04-01 Type: Private placement of convertible notes Raised: L500,000 ($710,550) Shares after offering: 43.7 million Investor: Bracknor …

    Published on 4/11/2016

< Previous   1  2  3  4  5  6  7  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993